Two Seas Capital LP Acquires 275,000 Shares of Sotera Health Company $SHC

Two Seas Capital LP raised its holdings in shares of Sotera Health Company (NASDAQ:SHC) by 4.7% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,111,053 shares of the company’s stock after acquiring an additional 275,000 shares during the period. Sotera Health makes up 1.3% of Two Seas Capital LP’s holdings, making the stock its 10th largest position. Two Seas Capital LP’s holdings in Sotera Health were worth $112,993,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in SHC. BlackRock Inc. bought a new position in shares of Sotera Health in the second quarter worth $428,635,000. Sculptor Capital LP bought a new stake in shares of Sotera Health during the second quarter valued at about $426,000,000. Jupiter Topco LLC acquired a new stake in Sotera Health in the second quarter worth about $149,137,000. Lakewood Capital Management LP acquired a new stake in Sotera Health in the second quarter worth about $70,638,000. Finally, Sachem Head Capital Management LP grew its position in Sotera Health by 47.2% in the 4th quarter. Sachem Head Capital Management LP now owns 11,645,000 shares of the company’s stock valued at $205,418,000 after buying an additional 3,735,000 shares in the last quarter. Institutional investors and hedge funds own 91.03% of the company’s stock.

Insider Buying and Selling at Sotera Health

In related news, insider Michael Rutz sold 150,000 shares of Sotera Health stock in a transaction on Friday, August 7th. The shares were sold at an average price of $18.84, for a total value of $2,826,000.00. Following the completion of the sale, the insider owned 334,279 shares of the company’s stock, valued at approximately $6,297,816.36. The trade was a 30.97% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Chairman Michael Petras, Jr. sold 850,000 shares of the company’s stock in a transaction on Monday, August 17th. The stock was sold at an average price of $18.50, for a total transaction of $15,725,000.00. Following the completion of the sale, the chairman owned 3,969,393 shares of the company’s stock, valued at $73,433,770.50. This represents a 17.64% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 1,294,515 shares of company stock worth $23,999,528. 15.36% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of research firms have commented on SHC. UBS Group set a $19.00 price target on shares of Sotera Health in a research report on Wednesday, June 24th. Barclays boosted their target price on Sotera Health from $19.00 to $22.00 and gave the stock an “overweight” rating in a report on Friday, August 7th. Weiss Ratings raised Sotera Health from a “hold (c)” rating to a “hold (c+)” rating in a research note on Tuesday, August 11th. Piper Sandler reiterated an “overweight” rating and set a $25.00 price target on shares of Sotera Health in a research report on Tuesday, September 8th. Finally, Citigroup boosted their price objective on Sotera Health from $23.00 to $25.00 and gave the stock a “buy” rating in a research note on Friday, August 7th. Eight investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, Sotera Health currently has a consensus rating of “Moderate Buy” and an average price target of $21.50.

Sotera Health Stock Down 1.6%

Shares of NASDAQ:SHC traded down $0.30 during midday trading on Tuesday, hitting $18.25. 1,654,087 shares of the stock were exchanged, compared to its average volume of 2,744,565. The company has a market capitalization of $5.21 billion, a PE ratio of 32.02 and a beta of 1.85. Sotera Health Company has a 52-week low of $13.09 and a 52-week high of $19.85. The company has a debt-to-equity ratio of 3.33, a quick ratio of 2.55 and a current ratio of 2.80. The business’s fifty day simple moving average is $18.69 and its two-hundred day simple moving average is $16.94.

Sotera Health (NASDAQ:SHC) last issued its earnings results on Thursday, August 6th. The company reported $0.26 earnings per share for the quarter, topping the consensus estimate of $0.24 by $0.02. Sotera Health had a return on equity of 40.12% and a net margin of 13.44%.The company had revenue of $321.38 million for the quarter, compared to analyst estimates of $309.70 million. During the same period in the prior year, the firm posted $0.20 EPS. The business’s revenue was up 9.2% compared to the same quarter last year. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. As a group, research analysts predict that Sotera Health Company will post 0.87 earnings per share for the current fiscal year.

Sotera Health Profile

Sotera Health Company (NASDAQ:SHC) is a global provider of healthcare services focused on sterilization, laboratory testing and infection prevention. The company serves medical device manufacturers, pharmaceutical companies, biotechnology businesses, hospitals and other healthcare organizations.

Sotera Health operates through three primary businesses. Sterigenics provides outsourced sterilization and medical device services using technologies such as ethylene oxide, gamma irradiation and electron beam processing.